In this cohort study of 414 209 participants in the UK Biobank study, the PNPLA3 I148M variant had synergistic associations with the risk of cirrhosis, hepatocellular carcinoma, and liver disease–related mortality along with excessive alcohol intake and obesity. Here, PNPLA3 is linked to liver disorder.